$Big Tree Cloud (DSY.US)$Arrived 🚀

$Novavax (NVAX.US)$
Furui Group analyst Roger Song maintains novavax (NVAX.US)a buy rating, maintaining a target price of $31.

$Novavax (NVAX.US)$ Is there still hope for my 20 books to be published?

$Novavax (NVAX.US)$ said Friday that doses of its updated vaccine to prevent COVID-19 in people at least 12 years old are now available in the US.
The company said its 2024-2025 formula COVID-19 vaccine is in stock at major pharmacy retailers nationwide.

$Novavax (NVAX.US)$
The airplane is starting to take off ✈️

$Aethlon Medical (AEMD.US)$
Today, close to 100,000 mpox vaccine doses will arrive in the Democratic Republic of Congo (DRC), making these the first delivery of the vaccine to the country. A second delivery amounting to around 100,000 vaccines is expected to arrive in the coming days.

$Novavax (NVAX.US)$
Six American biotechnology analysts have indicated that Novavax is approaching break-even. They forecast that the company will announce its final loss in 2024 and then achieve a profit of $29 million in 2025. Therefore, it is expected that the company will achieve a break-even point in just over a year. In order to reach the break-even point by 2025, the company must grow at what rate per year? According to the analysts' estimates, they expect the company to grow by an average of 76% year-on-year, which suggests that the analysts are confident. If the business growth rate slows down, the time to profitability will be later than expected.

$WiSA Technologies (WISA.US)$ I'm looking to get in for the break of 2.50 with 500 shares to start and scale up at 2.75 for the full 1000 shares. If all goes well I will sell 500 at $3 then sell 250 at 3.50, and dump the rest around 4-5. Any thoughts on this plan?

$WiSA Technologies (WISA.US)$
Preparing for takeoff 🛫

$Big Tree Cloud (DSY.US)$
What's the situation with the continuous rise?